Mastodon

Herbion® Hedera (Tablets, Syrup) Instructions for Use

ATC Code

R05CA12 (Hederae Helix folia)

Active Substance

Hederae Helix folia (Grouping Name)

Clinical-Pharmacological Group

Herbal preparation with expectorant effect

Pharmacotherapeutic Group

Drugs used for cough and colds; expectorants, excluding combinations with antitussives; mucolytic agents

Pharmacological Action

Herbal remedy. It has an expectorant, mucolytic, and antispasmodic effect due to the presence of saponins.

Indications

Use as an expectorant in the complex therapy of infectious and inflammatory diseases of the respiratory tract.

  • Administer for conditions accompanied by a cough with difficult-to-discharge sputum.

ICD codes

ICD-10 code Indication
J04 Acute laryngitis and tracheitis
J06.9 Acute upper respiratory infection, unspecified
J15 Bacterial pneumonia, not elsewhere classified
J20 Acute bronchitis
J37 Chronic laryngitis and laryngotracheitis
J42 Unspecified chronic bronchitis
R05 Cough
R09.3 Sputum
ICD-11 code Indication
CA05 Acute laryngitis or tracheitis
CA07.0 Acute upper respiratory tract infection of unspecified site
CA0G Chronic laryngitis or laryngotracheitis
CA20.1Z Chronic bronchitis, unspecified
CA40.0Z Bacterial pneumonia, unspecified
CA42.Z Acute bronchitis, unspecified
MD10 Abnormal sputum
MD12 Cough

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Take orally. Determine the dose, frequency, and duration of treatment individually, based on the clinical situation, the patient’s age, and the specific dosage form used.

Adhere strictly to the dosing instructions provided with the specific product packaging for the tablet or syrup formulation.

Adverse Reactions

Possible adverse reactions include allergic reactions, nausea, vomiting, and diarrhea.

Rarely, pain in the epigastric region may occur. Discontinue use and consult a physician if any adverse reactions are severe or persistent.

Contraindications

  • Do not use in patients with known hypersensitivity to ivy (Hedera helix) or any other component of the product.
  • Contraindicated in specific pediatric age groups depending on the dosage form; consult the product leaflet for age restrictions.

Use in Pregnancy and Lactation

Not recommended for use during pregnancy and lactation.

Pediatric Use

Use in children of appropriate age categories is possible according to indications, in recommended doses and dosage forms. It is necessary to strictly follow the instructions in the leaflets for ivy preparations regarding contraindications for the use of specific dosage forms of this product in children of different ages.

Special Precautions

During treatment, it is recommended to consume a sufficient amount of warm fluids (water, tea, etc.).

If there is no effect during treatment with the product for 5-7 days and/or if the condition worsens (appearance of asthma attacks, purulent sputum, fever), it is necessary to consult a doctor.

Drug Interactions

Avoid concomitant use with antitussive medications (e.g., codeine, dextromethorphan). This combination impedes the clearance of liquefied sputum and can increase the risk of respiratory complications.

No other clinically significant drug interactions are known.

Overdose

Symptoms of overdose may include nausea, vomiting, diarrhea, and gastritis due to the saponin content.

In case of suspected overdose, discontinue the medication immediately and initiate symptomatic and supportive treatment. Gastric lavage may be considered if a large amount was ingested recently.

Storage Conditions

Store at 8°C (46°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

Brand (or Active Substance), Marketing Authorisation Holder, Dosage Form

Marketing Authorization Holder

Krka d.d., Novo mesto (Slovenia)

Dosage Form

Bottle OTC Icon Herbion® ivy Lozenges 35 mg: 8, 16, 24, 32, or 40 pcs.

Dosage Form, Packaging, and Composition

Lozenges from light brown to brown in color, round, with beveled edges, with a rough surface; the presence of inclusions from yellow to brown, light spots, the presence of air bubbles and slight unevenness of the edges is allowed.

1 tab.
Extract of common ivy leaves* 35 mg

* produced from common ivy leaves (Hedera helix L., family Araliaceae); extractant – ethanol (ethyl alcohol) 30% (w/w).

Excipients : isomalt (type M) (E953), citric acid (E330), sucralose (E955), caramel flavor (natural flavoring substance, flavor preparation, propylene glycol (E1520), water), citrus flavor (natural flavoring substance, flavor preparation, butylated hydroxyanisole (E320)), peppermint leaf oil.

8 pcs. – blisters (1) – carton packs.
8 pcs. – blisters (2) – carton packs.
8 pcs. – blisters (3) – carton packs.
8 pcs. – blisters (4) – carton packs.
8 pcs. – blisters (5) – carton packs.

Marketing Authorization Holder

Krka d.d., Novo mesto (Slovenia)

Dosage Form

Bottle OTC Icon Herbion® ivy syrup Syrup: 150 ml bottle with dosing spoon

Dosage Form, Packaging, and Composition

Syrup yellowish-brown in color with a characteristic odor; opalescence is allowed.

1 ml
Dry extract of common ivy leaves (5-7.5:1)* 7 mg

* dry extract of common ivy leaves (5-7.5:1) is prepared from: common ivy leaves (common ivy Hedera helix L., family Araliaceae, folium) and ethanol 30% (extractant).

Excipients : sorbitol liquid (non-crystallizing, 70% aqueous solution) (E420) – 500 mg, glycerol (E422) – 200 mg, sodium benzoate (E211) – 2 mg, citric acid monohydrate (E330) – 0.3 mg, aromatic balsam** – 1 mg, purified water – up to 1 ml.

** Aromatic balsam contains propylene glycol (E1520), ethanol (E1510), citronella oil, citral from Litsea cubeba, lemon oil, coriander oil.

150 ml – dark glass bottles with first-opening control (1) complete with a dosing spoon – carton packs.

TABLE OF CONTENTS